Medicines Australia congratulates Health Minister and team

19 May 2025

Trade group Medicines Australia congratulates Mark Butler on his reappointment as the Minister for Health and Aging and for adding the portfolios of Disability and the National Disability Insurance Scheme to his remit.

Minister Butler can now fix what he acknowledges as a “clunky” Health Technology Assessment (HTA) system and strengthen the Pharmaceutical Benefits Scheme (PBS) for future generations.

Chief executive of Medicines Australia Elizabeth de Somer welcomed the reappointment of Minister Butler, noting his deep understanding of the complexities of the health portfolio including the PBS and the medicines industry.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK